Airsculpt Technologies vs LifeMD
AIRS and LFMD side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AIRS and LFMD compare
LifeMD is the larger company, worth 1.5 times as much as Airsculpt Technologies ($85.8M against $58.1M).
LifeMD grew revenue faster over the last twelve months (3.8% versus −6.3% for Airsculpt Technologies).
LifeMD keeps more of each dollar of sales as profit, with a net margin of 0.12% compared with −6.4% at Airsculpt Technologies.
LifeMD scores higher on the StockData Score (12 against 4 for Airsculpt Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AIRS | LFMD |
|---|---|---|
| Size and price | ||
| Market cap | $58.1M | $85.8M |
| Share price | $0.805 | $1.78 |
| Change, 1 year | −87.3% | −65.3% |
| Change, 5 years | −94.6% | −60.8% |
| Beta (5Y) | 2.44 | 1.71 |
| Employees | 330 | 389 |
| StockData Score | ||
| Total score | 4 | 12 (better) |
| Valuation score | 2 | 2 |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 1 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.4× (better) | 0.5× |
| P/B | 0.5× (better) | 10.8× |
| EV/EBITDA | 16.0× | – |
| FCF yield | −4.4% (better) | −12.9% |
| Fair value | – | $2.38 |
| Margin of safety | – | 25.3% |
| Growth | ||
| Revenue growth (TTM) | −6.3% | 3.8% (better) |
| Revenue growth, 5Y average | 19.3% | 39.1% (better) |
| Profitability | ||
| Gross margin | 60.2% | 86.1% (better) |
| Operating margin | −4.7% (better) | −14.7% |
| Net margin | −6.4% | 0.12% (better) |
| FCF margin | −1.7% (better) | −6.7% |
| Return on equity | −10.1% | 6.5% (better) |
| Return on invested capital | −4.2% | – |
| Financial health | ||
| Debt / equity | 0.35 (better) | 0.00 |
| Net debt / EBITDA | 4.33 | – |
| Interest coverage | −1.4× | – |
| Current ratio | 0.85 | 0.90 (better) |
| Altman Z-score | 0.68 (better) | −3.44 |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Payout ratio | – | 1545% |
| Buyback yield | −54.6% | – |
| Shareholder yield | −54.6% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 63.3% | 44.9% |
| Held by insiders | 76.5% | 18.2% |
| Insider net buying, 12 months | $2.0M (better) | −$54.1K |
| Short interest, % of float | 19.1% | – |
Go deeper
- AIRS stock overview
- AIRS income statement
- AIRS valuation and score
- LFMD stock overview
- LFMD income statement
- LFMD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.